文献速递胃肠外科肝胆胰外科围术期管理与 ERAS

择期腹部手术围术期益生菌或合生元:系统综述与随机对照试验Meta分析

Perioperative Probiotics or Synbiotics in Adults Undergoing Elective Abdominal Surgery: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
PubMed 文献 · Ann Surg · 2020-01-01

该系统综述与Meta分析纳入34项随机对照试验共2723例择期腹部手术成人患者,评估围术期益生菌或合生元对术后结局的影响。结果显示,干预组术后感染并发症风险显著降低(RR 0.56;95%CI 0.46-0.69;P<0.00001),合生元效果优于单用益生菌,且合生元组总住院时间缩短,死亡率与非感染并发症无显著差异,制剂耐受良好。

要点

  • 择期腹部手术围术期使用益生菌或合生元可显著降低术后感染并发症风险。
  • 合生元对术后感染的预防效果优于单用益生菌,并可缩短总住院时间。
  • 干预组死亡率与非感染并发症与对照组无显著差异,制剂耐受良好。

核心结论

  • 益生菌和合生元是安全有效的营养辅助剂,可减少择期腹部手术后感染并发症,其中合生元效果最佳。

研究设计与样本

  • 系统综述与随机对照试验Meta分析,检索PubMed、Embase和WHO Global Index Medicus数据库,纳入34项随机对照试验共2723例择期结直肠、上消化道、移植或肝胆胰手术成人患者。

主要发现

  • 围术期益生菌或合生元显著降低腹部手术后感染并发症风险(RR 0.56;95%CI 0.46-0.69;P<0.00001;n=2723;I²=42%)。
  • 合生元对术后感染的效果优于单用益生菌(合生元RR 0.46;95%CI 0.33-0.66;P<0.0001;n=1399;I²=53%;益生菌RR 0.65;95%CI 0.53-0.80;P<0.0001;n=1324;I²=18%)。
  • 合生元组总住院时间缩短(加权均数差-3.89天;95%CI -6.60至-1.18;P=0.005;n=535;I²=91%),单用益生菌组无显著差异(RR -0.65;95%CI -2.03至0.72;P=0.35;n=294;I²=65%)。
  • 干预组与对照组死亡率(RR 0.98;95%CI 0.54-1.80;P=0.96;n=1729;I²=0%)和非感染并发症无显著差异。
  • 制剂耐受良好,未报告显著不良事件。

临床怎么用

  • 对择期腹部手术成人患者,可考虑围术期使用益生菌或合生元以降低术后感染并发症风险。
  • 合生元在降低术后感染和缩短住院时间方面可能优于单用益生菌,选择制剂时可优先考虑合生元。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To define the impact of perioperative treatment with probiotics or synbiotics on postoperative outcome in patients undergoing abdominal surgery. BACKGROUND: Postoperative surgical infection accounts for a third of all cases of sepsis, and is a leading cause of morbidity and mortality. Probiotics, prebiotics, and synbiotics (preparations that combine probiotics and prebiotics) are nutritional adjuncts that are emerging as novel therapeutic modalities for preventing surgical infections. However, current evidence on their effects is conflicting. METHODS: A comprehensive search of the PubMed, Embase, and WHO Global Index Medicus electronic databases was performed to identify randomized controlled trials evaluating probiotics or synbiotics in adult patients undergoing elective colorectal, upper gastrointestinal, transplant, or hepatopancreaticobiliary surgery. Bibliographies of studies were also searched. The primary outcome measure was incidence of postoperative infectious complications. Secondary outcomes included incidence of noninfectious complications, mortality, length of hospital stay, and any treatment-related adverse events. Quantitative pooling of the data was undertaken using a random effects model. RESULTS: A total of 34 randomized controlled trials reporting on 2723 participants were included. In the intervention arm, 1354 patients received prebiotic or symbiotic preparations, whereas 1369 patients in the control arm received placebo or standard care. Perioperative administration of either probiotics or synbiotics significantly reduced the risk of infectious complications following abdominal surgery [relative risk (RR) 0.56; 95% confidence interval (CI) 0.46-0.69; P < 0.00001, n = 2723, I = 42%]. Synbiotics showed greater effect on postoperative infections compared with probiotics alone (synbiotics RR: 0.46; 95% CI: 0.33-0.66; P < 0.0001, n = 1399, I = 53% probiotics RR: 0.65; 95% CI: 0.53-0.80; P < 0.0001, n = 1324, I = 18%). Synbiotics but not probiotics also led to a reduction in total length of stay (synbiotics weighted mean difference: -3.89; 95% CI: -6.60 to -1.18 days; P = 0.005, n = 535, I = 91% probiotics RR: -0.65; 95% CI: -2.03-0.72; P = 0.35, n = 294, I = 65%). There were no significant differences in mortality (RR: 0.98; 95% CI: 0.54-1.80; P = 0.96, n = 1729, I = 0%) or noninfectious complications between the intervention and control groups. The preparations were well tolerated with no significant adverse events reported. CONCLUSIONS: Probiotics and synbiotics are safe and effective nutritional adjuncts in reducing postoperative infective complications in elective abdominal surgery. The treatment effects are greatest with synbiotics.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Chowdhury AH, Adiamah A, Kushairi A, et al. Perioperative Probiotics or Synbiotics in Adults Undergoing Elective Abdominal Surgery: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Ann Surg. 2020. PMID: 31469748. doi:10.1097/SLA.0000000000003581

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。